神経刺激装置の世界市場2019年-2027年

◆英語タイトル:Neurostimulation Devices - Global Market Outlook (2019-2027)
◆商品コード:SMRC21FB264
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年10月
◆ページ数:約150 
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは、世界の神経刺激装置市場規模について調査し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別(外部型、埋込可能型)分析、製品別(人工内耳(CI)、脊髄刺激装置(SCS)、脳深部刺激療法(DBS)、仙骨神経刺激装置(SNS)、胃電気刺激装置(GES))分析、エンドユーザー別(病院、研究機関/科学研究所、認知ケアセンター、リハビリセンター、医療クリニック)分析、用途別(神経学的障害、慢性疼痛、運動障害、虚血、治療抵抗性うつ病(TRD))分析、地域別分析、主要な市場開拓、企業情報など、以下の構成でまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の神経刺激装置市場規模:種類別(外部型、埋込可能型)
・世界の神経刺激装置市場規模:製品別(人工内耳(CI)、脊髄刺激装置(SCS)、脳深部刺激療法(DBS)、仙骨神経刺激装置(SNS)、胃電気刺激装置(GES))
・世界の神経刺激装置市場規模:エンドユーザー別(病院、研究機関/科学研究所、認知ケアセンター、リハビリセンター、医療クリニック)
・世界の神経刺激装置市場規模:用途別(神経学的障害、慢性疼痛、運動障害、虚血、治療抵抗性うつ病(TRD))
・世界の神経刺激装置市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Neurostimulation Devices Market is accounted for $5.61 billion in 2019 and is expected to reach $16.58 billion by 2027 growing at a CAGR of 14.5% during the forecast period. Some of the key factors propelling the growth of the market are growing prevalence of neurological disorders, growing adoption of innovative products, and rising demand for minimally invasive surgery. However, the lack of skilled healthcare practitioners is the restraining factor for the growth of the market.

Equipment used for neuromodulation is known as neurostimulation device. This device helps in the treatment of neurologic disorders by assuring the delivery of electrical stimulation to the intended parts of the patient’s brain, peripheral nervous system, and spinal cord.

By product, the spinal cord stimulators (SCS) segment is expected to grow at a significant market share during the forecast period owing to the high market penetration of commercially available products in this segment. Based on geography, North America is anticipated to hold considerable market share during the forecast period which is attributed to the growing geriatric population, changing lifestyles, and increasing consumption of alcohol and junk food.

Some of the key players in Neurostimulation Devices Market include Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Electromedical Products International (EPI), NeuroPace, Inc., Aleva Neurotherapeutics SA, BioControl Medical, EnteroMedics Inc, Bioness Inc, Autonomic Technologies, Neuronetics, Inc, Multi Radiance Medical, Inc, American Imex, Amrex Electrotherapy Equipment, Synapse Biomedical, LivaNova PLC, DePuy Synthes Inc, NeuroSigma Inc, Abbott Laboratories, and Integer Holdings Corporation.

Types Covered:
• External
• Implantable

Products Covered:
• Cochlear Implants (CI)
• Spinal Cord Stimulators (SCS)
• Deep Brain Stimulators (DBS)
• Sacral Nerve Stimulators (SNS)
• Gastric Electric Stimulators (GES)
• Percutaneous Tibial Nerve Stimulators
• Auditory Brainstem Implant
• Hypoglossal Nerve Stimulation
• Transcranial Magnetic Stimulators
• Vagus Nerve Stimulators (VNS)

End Users Covered:
• Hospitals
• Research Institutes/Scientific Research Laboratories
• Cognitive Care Centers
• Rehabilitation Centers
• Medical Clinic
• Ambulatory Surgery Centers
• Specialty Clinics

Applications Covered:
• Neurological Disorders
• Chronic Pain
• Movement Disorders
• Ischemia
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Hearing Loss
• Gastroparesis
• Pain Management
• Neurologic Urinary and Fecal Incontinence
• Essential Tremor
• Depressive Disorder
• Dystonia
• Respiratory Disorders

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
France
Italy
UK
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurostimulation Devices Market, By Type
5.1 Introduction
5.2 External
5.2.1 Transcranial Magnetic Stimulation (TMS)
5.2.2 Transcutaneous Electrical Nerve Stimulation (TENS)
5.3 Implantable
6 Global Neurostimulation Devices Market, By Product
6.1 Introduction
6.2 Cochlear Implants (CI)
6.3 Spinal Cord Stimulators (SCS)
6.4 Deep Brain Stimulators (DBS)
6.5 Sacral Nerve Stimulators (SNS)
6.6 Gastric Electric Stimulators (GES)
6.7 Percutaneous Tibial Nerve Stimulators
6.8 Auditory Brainstem Implant
6.9 Hypoglossal Nerve Stimulation
6.10 Transcranial Magnetic Stimulators
6.11 Vagus Nerve Stimulators (VNS)
6.11.1 Noninvasive Vagus Nerve Stimulator
6.11.2 Invasive Vagus Nerve Stimulator
7 Global Neurostimulation Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Research Institutes/Scientific Research Laboratories
7.4 Cognitive Care Centers
7.5 Rehabilitation Centers
7.6 Medical Clinic
7.7 Ambulatory Surgery Centers
7.8 Specialty Clinics
8 Global Neurostimulation Devices Market, By Application
8.1 Introduction
8.2 Neurological Disorders
8.2.1 Alzheimer’s
8.2.2 Epilepsy
8.2.3 Parkinson’s Disease
8.3 Chronic Pain
8.4 Movement Disorders
8.5 Ischemia
8.6 Treatment Resistant Depression(TRD)
8.7 Obsessive Compulsive Disorder(OCD)
8.8 Hearing Loss
8.9 Gastroparesis
8.10 Pain Management
8.11 Neurologic Urinary and Fecal Incontinence
8.12 Essential Tremor
8.13 Depressive Disorder
8.14 Dystonia
8.15 Respiratory Disorders
9 Global Neurostimulation Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Medtronic
11.2 Cyberonics
11.3 Boston Scientific Corporation
11.4 St. Jude Medical
11.5 Nevro Corporation
11.6 Electromedical Products International (EPI)
11.7 NeuroPace, Inc.
11.8 Aleva Neurotherapeutics SA
11.9 BioControl Medical
11.10 EnteroMedics Inc
11.11 Bioness Inc
11.12 Autonomic Technologies
11.13 Neuronetics, Inc
11.14 Multi Radiance Medical, Inc
11.15 American Imex
11.16 Amrex Electrotherapy Equipment
11.17 Synapse Biomedical
11.18 LivaNova PLC
11.19 DePuy Synthes Inc
11.20 NeuroSigma Inc
11.21 Abbott Laboratories
11.22 Integer Holdings Corporation



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[神経刺激装置の世界市場2019年-2027年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆